News & Events

• September 16, 2021
  

  C-Path Appoints Tufts’ Jonathan M. Davis as Senior Advisor in Pediatrics

  C-Path today announced the appointment of Jonathan M. Davis, M.D., as Senior Advisor in Pediatrics working with its International Neonatal Consortium (INC) and advising on drug and device development in infants and children, effective immediately.

• September 15, 2021
  

  Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program

  The Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP^®) officially launched its next phase on Tuesday establishing itself as the leading platform to accelerate rare disease treatment innovation. The launch was part of an all-day virtual workshop and annual meeting of rare disease stakeholders, featuring a platform demonstration, industry expert presentations and attendance by over 400 patients, providers, researchers, clinicians, biopharmaceutical companies, regulatory reviewers and scientists.

• September 13, 2021
  

  C-Path and RARE-X Establish New Collaboration for Rare Disease Data Sharing

  Critical Path Institute (C-Path), who’s aim is to catalyze the development of new approaches that advance medical innovation and regulatory science, today announced a collaboration with RARE-X to improve ways researchers can access and analyze patient data. RARE-X is a nonprofit organization dedicated to enabling patient communities to collect, manage and share their de-identified data to advance research.

• September 1, 2021
  

  Breaking Down Data Siloes: New Analytics Platform Sparks Opportunity for Rare Disease Field

  On Tuesday, September 14, 10 a.m. – 3:45 p.m. ET, the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®), an FDA-funded initiative, will have its public premiere during the annual meeting for the project. The platform will host, standardize and share rare diseases data as part of its functionality.

• August 23, 2021
  

  ePRO Consortium Welcomes Medable

  C-Path is proud to welcome Medable, Inc as the newest member of its Electronic Patient-Reported Outcome Consortium. Comprised of 14 firms that provide electronic data collection technologies and services for capturing patient-reported outcome and other clinical outcome assessment data in clinical trials, ePRO Consortium members collaborate in a pre-competitive environment to support and conduct novel research, design and deliver educational resources, and develop and disseminate best practice recommendations for the electronic collection of clinical outcome data. Welcome aboard, Medable!